Cargando…
MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update
Diabetic kidney disease (DKD) is a life‐limiting condition characterized by progressive and irreversible loss of renal function. Currently, the estimated glomerular filtration rate (eGFR) and albuminuria are used as key markers to define DKD. However, they may not accurately indicate the degree of r...
Autores principales: | Cao, Qinghua, Chen, Xin‐Ming, Huang, Chunling, Pollock, Carol A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996361/ https://www.ncbi.nlm.nih.gov/pubmed/32123840 http://dx.doi.org/10.1096/fba.2018-00064 |
Ejemplares similares
-
Mesenchymal Stem Cell-Derived Exosomes: Toward Cell-Free Therapeutic Strategies in Chronic Kidney Disease
por: Cao, Qinghua, et al.
Publicado: (2022) -
The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease
por: Huang, Chunling, et al.
Publicado: (2021) -
MicroRNAs: new biomarkers and promising therapeutic targets for
diabetic kidney disease
por: do Nascimento, Linicene Rosa, et al.
Publicado: (2019) -
MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury
por: Tsuji, Kenji, et al.
Publicado: (2023) -
MicroRNA and diabetic retinopathy—biomarkers and novel therapeutics
por: Smit-McBride, Zeljka, et al.
Publicado: (2021)